About PolpharmaWe are the largest Polish manufacturer of pharmaceuticals and a leader of the Polish pharmaceutical market. We actively operate in the markets of Central and Eastern Europe, the Caucasus and Central Asia.
ResponsibilityBeing the largest Polish pharmaceutical company we want to help people to live a healthy life in a healthy world. Social responsibility is an integral part of the management strategy in our company.
CareerPolpharma's development is possible only thanks to the commitment of our employees as well as the involvement of students and graduates in various business areas.
Agata Łapińska-Smolińska PresidentAn expert in the pharmaceutical industry, in which she has held a management position for 20 years. Head of numerous projects. Director of HCP Marketing Department at Polpharma.
Krzysztof Kurowski Vice PresidentOver 20 years of experience in the pharmaceutical industry, particularly in research and development. A pharmacist by education.
Beata Kamosińska MemberDoctor of Medical Sciences. In the pharmaceutical industry for over 20 years. She represents the Medical Department of Polpharma.
Marcin Lewandowski MemberRelationship and Content Expert. Doctoral student at the Faculty of Medicine of the Cardinal Stefan Wyszyński University in Warsaw. Graduate of the Faculty of Journalism and Political Science of the University of Warsaw. In Polpharma since 2010.
Daniela Piotrowska Director of Polpharma Scientific FoundationExpert with over ten years of experience in business organization management. Lawyer, graduate of postgraduate studies in management at the Warsaw School of Economics.
Grzegorz Kotowski Chairman of the Supervisory BoardOver ten years of experience in managerial positions in companies associated with Jerzy Starak. He is a legal advisor entered in the list of the District Chamber of Legal Advisors in Warsaw. He has been working at Polpharma for over 15 years.
Igor Kania Member of the Supervisory BoardAttorney at law specializing in pharmaceutical and medical law, international business and M&A transactions. He has been associated with Zakłady Farmaceutyczne Polpharma SA since 2005. Currently, Head of the Legal Department in Poland at Polpharma
Scientific Council Jarosław Reguła, MD, PhD – Chairman of the Scientific Council, internal diseases and gastroenterologyMarcin Gruchała, MD, PhD – internal medicine and cariologyAdam Kobayashi, MD, PhD – internal medicine and neurologyPiotr Kuna, MD, PhD – internal diseases and allergologyKrzysztof Narkiewicz, MD, PhD – internal medicine, cariology and hypertensiologyGrzegorz Opolski, MD, PhD – internal medicine and cardiologyAleksander Prejbisz, MD, PhD – internal medicine, cariology and hypertensiologyJacek Szaflik MD, PhD – ophthalmologyMirosław Wielgoś, MD, PhD – gynecology and obstetrics, perinatologyKatarzyna Życińska, MD, PhD – internal medicine, nephrology and family medicine
Scientific Council of Honour prof. dr hab. Waldemar Banasiak, MD, PhD – cardiologyprof. dr hab. Stefan Chłopicki, MD, PhD – experimental pharmacology, Director of Jagiellonian Centre for Experimental TherapeuticsZbigniew Gaciong, MD, PhD – internal medicineprof. dr hab. Grzegorz Grynkiewicz, MD, PhD – organic, medical and pharmaceutical chemistryprof. dr hab. Marek Jarema, MD, PhD – psychiatry dr Wojciech Kuźmierkiewiczprof. dr hab. Roman Lorenc, MD, PhD – medicine and biochemistryAdam Płaźnik, MD, PhD – pharmacology and psychopharmacologyprof. dr hab. Edmund Przegialiński, MD, PhD – pharmacologyprof. dr hab. Jacek Rożniecki – neurologyprof. dr hab. Jacek Spławiński, MD, PhD – pharmacologyprof. dr hab. Cezary Szczylik, MD, PhD – oncologyprof. dr hab. med. Kazimierz Roszkowski-Śliż, MD, PhD – clinical oncologyprof. dr hab. Jerzy Szaflik, MD, PhD – ophthalmologyprof. dr hab. Edward Franek, MD, PhD – internal medicine, endocrinology, nephrologyprof. dr hab. Marian Zembala, MD, PhD – cardiac surgery and transplantology
